Introduction to Focus on Fabry Nephropathy: Biomarkers, Progression, and Disease Severity

被引：2
|
作者：
Warnock, David G. [1 ]
Remuzzi, Giuseppe [2 ,3 ]
Brenner, Barry M. [4 ]
Levin, Adeera [5 ]
Wanner, Christoph [6 ]
机构：
[1] Univ Alabama, Dept Med, Div Nephrol, Birmingham, AL 35294 USA
[2] Mario Negri Inst Pharmacol Res, Dept Renal Med, Clin Res Ctr Rare Dis Aldo & Cele Dacco, Bergamo, Italy
[3] Azienda Osped Osped Riuniti Bergamo, Nephrol Unit, Bergamo, Italy
[4] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA
[5] St Pauls Hosp, Dept Med, Vancouver, BC V6Z 1Y6, Canada
[6] Univ Wurzburg, Dept Med, Wurzburg, Germany
来源：
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2010年 / 5卷 / 02期
关键词：
D O I：
10.2215/CJN.08191109
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：359 / 359
页数：1
相关论文
共 50 条
  • [21] Biomarkers to Predict Progression in IgA Nephropathy
    Cheung, Chee Kay
    Barratt, Jonathan
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2019, 14 (10): : 1421 - 1423
  • [22] Fabry disease: Correlation of progression of white matter disease and severity of neurological manifestations with the pulvinar sign
    Shankar, Suma
    Weisiger, Kara
    Hogue, Jacob
    Josephson, Andrew
    Packman, Seymour
    MOLECULAR GENETICS AND METABOLISM, 2009, 96 (02) : S40 - S40
  • [23] Effect of enzyme replacement therapy on fabry nephropathy progression
    Nowak, Albina
    Koch, Gilbert
    Huynh-Do, Uyen
    Siegenthaler, Martin
    Marti, Hans-Peter
    Battegay, Edouard
    Pfister, Marc
    SWISS MEDICAL WEEKLY, 2015, 145 : 16S - 17S
  • [24] Cardiac biomarkers in Fabry disease
    Nandi, Pooja
    Ellis, Robert
    Veleva-Rotse, Biliana O.
    Hiros, Jennifer
    Howard, Paul
    MOLECULAR GENETICS AND METABOLISM, 2024, 141 (02)
  • [25] Coexistence of Fabry Disease and Membranous Nephropathy
    Liu, Ying
    Xie, Hua
    Lin, Hongli
    Chen, Shuni
    Wang, Weidong
    Zhao, Guangben
    Zhang, Xu
    IRANIAN JOURNAL OF KIDNEY DISEASES, 2016, 10 (01) : 48 - 50
  • [26] The coincidence of IgA nephropathy and Fabry disease
    Maixnerova, Dita
    Tesar, Vladimir
    Rysava, Romana
    Reiterova, Jana
    Poupetova, Helena
    Dvorakova, Lenka
    Golan, Lubor
    Neprasova, Michaela
    Kidorova, Jana
    Merta, Miroslav
    Honsova, Eva
    BMC NEPHROLOGY, 2013, 14
  • [27] The coincidence of IgA nephropathy and Fabry disease
    Dita Maixnerová
    Vladimír Tesař
    Romana Ryšavá
    Jana Reiterová
    Helena Poupětová
    Lenka Dvořáková
    Lubor Goláň
    Michaela Neprašová
    Jana Kidorová
    Miroslav Merta
    Eva Honsová
    BMC Nephrology, 14
  • [28] Cardiac disease progression in Fabry Disease
    Gatterer, C.
    Lang, I.
    Mundigler, G.
    Graf, S.
    Bergler-Klein, J.
    Hengstenberg, C.
    Loewe, C.
    Weidenauer, D.
    Sunder-Plassmann, G.
    Beitzke, D.
    WIENER KLINISCHE WOCHENSCHRIFT, 2018, 130 : 67 - 68
  • [29] 7th Update on Fabry Disease: Biomarkers, Progression and Treatment Opportunities in 2022
    不详
    NEPHRON, 2022, 146 (SUPPL 1) : 1 - 51
  • [30] Fabry disease: progression of nephropathy, and prevalence of cardiac and cerebrovascular events before enzyme replacement therapy
    Schiffmann, Raphael
    Warnock, David G.
    Banikazemi, Maryam
    Bultas, Jan
    Linthorst, Gabor E.
    Packman, Seymour
    Sorensen, Sven Asger
    Wilcox, William R.
    Desnick, Robert J.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2009, 24 (07) : 2102 - 2111
12345